C. Luparello et al., Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells, BREAST CANC, 54(3), 1999, pp. 235-244
In the present paper, we have examined whether human tissue inhibitor of me
talloprotease-1 (hTIMP-1) is able to exert a growth factor-like effect on t
wo clonal cell lines (BC-3A and BC-61), isolated from a parental line of hu
man breast carcinoma cells (8701-BC), and endowed with different growth and
invasive behaviour 'in vitro' and in nude mouse. The data obtained indicat
e that only the more tumorigenic clonal cell line (BC-61) is responsive to
hTIMP-1 treatment by increasing its proliferative rate in a dose-dependent
manner. It was also found that BC-61 cells selectively express a transmembr
ane protein of about 80 kDa able to bind hTIMP-1 'in vitro' and 'in vivo' w
ith high affinity (K-d of 0.07 +/- 0.004 nM), and that treatment of BC-61 c
ells with a proliferation-promoting concentration of hTIMP-1 is able to sti
mulate tyrosine-targeted phosphorylation. The cumulative results obtained s
trongly support the hypothesis that hTIMP-1, 'classically' regarded as a co
llagenase inhibitor, may be a crucial element of the extracellular signalli
ng network during breast cancer development by controlling cell growth phen
otype in autocrine and paracrine manner, and that intratumoural heterogenei
ty for the biological response to TIMP-1 may exist within the composite cel
l population of the primary tumour site.